Preparation method of acanthopanax extract

Through the combination of methanol dissolution and high-performance liquid chromatography, the problems of complex composition and low purity of the prickly extract were solved, and high-purity prickly extract extract was obtained, which was suitable for industrial production and reduced in treatment. Risk of adverse reactions.

CN118924800APending Publication Date: 2024-11-12STARTBAHNWEST AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410989005.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

In the prior art, the components of the prickly Vulcan extract are complex, have low purity, and are not suitable for large-scale industrial production, resulting in possible adverse reactions in treatment and delaying the optimal treatment period.

Method used

The separation and purification were performed by methanol dissolution treatment and high-performance liquid chromatography. Through multiple filtration and salt conversion steps, a high-purity prickly extract was obtained, including ultrasonic dissolution, C18 silica gel column separation, reduced pressure distillation and Freeze-drying and other steps.

Benefits of technology

It has achieved efficient purification of single-component prickly Vulcan extract, with a purity of more than 95%, suitable for large-scale industrial production and reduces the risk of adverse reactions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924800A_ABST
    Figure CN118924800A_ABST
Patent Text Reader

Abstract

The invention discloses an acanthopanax extract as well as a preparation method and application thereof, and belongs to the technical field of medicinal plant extraction. In order to solve the technical problems that an acanthopanax senticosus extract prepared by an extraction method in the prior art is complex in component, relatively low in purity and not suitable for industrial production, the invention provides a preparation method of an acanthopanax senticosus extract. And further refining and purifying by using a high performance liquid chromatography to finally obtain the single-component acanthopanax extract with the purity of more than 95%. According to the preparation method, the single-component acanthopanax extract can be increased to 95% or above, the preparation method is easy and convenient to operate and suitable for industrial large-scale production, and the acanthopanax extract can be applied to preparation of drugs with acanthopanax as the main component.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medicinal plant extraction and relates to a method for preparing a plant extract. Background Art

[0002] Acanthopanax senticosus is the dried root and rhizome of the Araliaceae plant (Acanthopanax senticosus), which is mainly distributed in Northeast my country and North China, and is very rich in resources. Studies have found that seven glycosides can be isolated from the rhizome of Acanthopanax senticosus, namely eleutheroside A, B, C, D, E, F and G. Among them, the roots of Araliaceae plants contain 0.6-0.9% eleutheroside E, and the stems of Araliaceae plants contain 0.6-1.5% eleutheroside E. It also contains substances such as polysaccharides and isoflavones. Compounds combined with alcohol, ethanol, hydrogen groups, etc. in sugar reducing groups are collectively called glycosides. They have the function of maintaining human health. After research and analysis, the main components are various sugars, amino acids, fatty acids, vitamins A, B1, B2 and a large amount of carotene, as well as sesame, sterols, coumarins, flavonoids, suberin, non-aromatic unsaturated organic acids, and various trace minerals. Its main active ingredients are believed to be eleutheroside B and eleutheroside E.

[0003] Pharmacologically, eleutheroside B has the effects of hemostasis, anti-hepatotoxicity, and improvement of liver function; eleutheroside E has the effects of immune regulation, strengthening the body, anti-fatigue, improving the body's adaptability, improving blood circulation, and preventing seminal vesicle and prostate atrophy.

[0004] Clinically, Acanthopanax injection containing Acanthopanax glycoside B and Acanthopanax glycoside E has been widely used in the treatment of diseases such as transient cerebral ischemia, cerebral arteriosclerosis, cerebral thrombosis, cerebral embolism, etc., but the Acanthopanax injection used clinically in the prior art is a mixture, which contains Acanthopanax glycoside A, Acanthopanax glycoside B1, Acanthopanax glycoside C, Acanthopanax glycoside D and Acanthopanax glycoside E, etc. in addition to the main active ingredients Acanthopanax glycoside B and Acanthopanax glycoside E; in treatment, unexplained adverse reactions may occur due to the complex ingredients, and the corresponding treatment cannot be carried out in time, delaying the best treatment period. Therefore, how to obtain a high-purity Acanthopanax extract becomes very important, and the reflux extraction method is generally used in the extraction process of the Acanthopanax active ingredients in the prior art. The Acanthopanax extract obtained by this method has complex ingredients, and Acanthopanax glycoside B and Acanthopanax glycoside E cannot be obtained alone. In addition, the extract of the reflux extraction method is heated for a long time, which is easy to destroy the thermally unstable components, and the solvent consumption is large, which is not suitable for industrial mass production.

[0005] Therefore, the art has been eager to develop a method for preparing a single extract of Acanthopanax senticosus with high efficiency and purity, and suitable for large-scale industrial production. Summary of the invention

[0006] In order to solve the technical problems that the extract obtained by the extraction method in the prior art has complex components, low purity and is not suitable for industrial production, the present invention provides a method for preparing an acanthopanax senticosus extract extract.

[0007] One of the purposes of the present invention is to provide a method for preparing an extract of Acanthopanax senticosus extract, the preparation method comprising the following steps:

[0008] S1: using methanol to dissolve the Acanthopanax senticosus extract, filtering and discarding the residue, repeating the above dissolving and filtering steps 3 times to obtain an Acanthopanax senticosus mixed solution;

[0009] S2: using high performance liquid chromatography to separate and purify the Acanthopanax senticosus mixed solution obtained in S1 to obtain a crudely purified Acanthopanax senticosus mixed solution;

[0010] S3: Select the crudely purified Acanthopanax senticosus single component solution obtained in S2, purify and convert the solution into salt by high performance liquid chromatography, perform vacuum distillation, and freeze-dry to obtain a purified single component Acanthopanax senticosus extract.

[0011] In a preferred embodiment of the present invention, the dissolution treatment in S1 is dissolution under ultrasonic conditions for 30 minutes.

[0012] In a preferred embodiment of the present invention, the filtration in S1 is performed using a filter membrane with a pore size of 0.45 um.

[0013] In a preferred embodiment of the present invention, the separation and purification step described in S2 is: using methanol as the organic phase, trifluoroacetic acid / water solution as the inorganic phase, and C18 silica gel column as the stationary phase, and using high performance liquid chromatography to separate and purify; the concentration of the trifluoroacetic acid solution is 0.1%.

[0014] In a preferred embodiment of the present invention, the purification step described in S3 is: using acetonitrile solution as the organic phase, trifluoroacetic acid / water or acetic acid aqueous solution as the inorganic phase, and C18 silica gel column as the stationary phase, and purifying by high performance liquid chromatography; the concentration of the acetonitrile solution is 5%, and the concentration of the acetic acid aqueous solution is 0.08%.

[0015] In a preferred embodiment of the present invention, the single-ingredient Acanthopanax senticosus extract in S3 is any one of eleutheroside A, eleutheroside B, eleutheroside C, eleutheroside D, eleutheroside E, eleutheroside F or eleutheroside G extract.

[0016] In a preferred embodiment of the present invention, the salt conversion step described in S3 is: first rinse the sample with acetonitrile and ammonium acetate solution, then rinse the sample with acetonitrile and acetic acid aqueous solution, and finally elute the sample with water and acetonitrile as mobile phases; the concentration of the ammonium acetate solution is 50 mmol.

[0017] In a preferred embodiment of the present invention, the reduced pressure distillation step in S3 is: firstly distill under reduced pressure in a water bath at 30°C for 2 hours, and then distill under reduced pressure in a water bath at 33°C for 4 hours.

[0018] The second object of the present invention is to provide an Acanthopanax senticosus extract, which is obtained by the above-mentioned preparation method.

[0019] The third object of the present invention is to provide the use of the above-mentioned Acanthopanax senticosus extract in the preparation of Acanthopanax senticosus medicine.

[0020] Beneficial Effects

[0021] The invention provides a method for preparing an acanthopanax extract, which can separate a single-component acanthopanax extract. The invention uses reverse high-performance liquid chromatography to separate and purify the components contained in the acanthopanax extract, so as to obtain a mixed solution of acanthopanax extract with a purity greater than 80%, and then uses high-performance liquid chromatography to purify the extract, so as to obtain a single-component acanthopanax extract with a purity greater than 90%. Finally, high-performance liquid chromatography is used for salt conversion (desalting), so as to remove the acid radical ions contained in the mobile phase used in the purification and refining process, so as to obtain a single-component acanthopanax extract with a purity greater than 95%. The invention solves the technical problems that the acanthopanax extract prepared by the extraction method in the prior art has complex components and is a mixture of multiple components, and the purity of each component in the mixture is low.

[0022] The preparation method provided by the present invention can obtain a high-purity Acanthopanax senticosus extract, and can achieve the purpose of increasing the purity of the Acanthopanax senticosus extract to more than 95%. The preparation method provided is simple to operate and is suitable for large-scale industrial production. The Acanthopanax senticosus extract provided can be used to prepare a medicine with Acanthopanax senticosus as the main ingredient. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is the HPLC quality test chart of Acanthopanax senticosus extract before preparation in Examples 1 and 2;

[0024] Figure 2 This is a HPLC preparation diagram of eleutheroside separated and purified in step S2 of Examples 1 and 2;

[0025] Figure 3 The HPLC test result of the eleutheroside B sample obtained in step S2 of Example 1;

[0026] Figure 4 This is the HPLC preparation diagram of eleutheroside B separated and purified in step S3 of Example 1;

[0027] Figure 5 The HPLC test result of the eleutheroside B sample obtained in step S3 of Example 1;

[0028] Figure 6 This is the HPLC preparation diagram of eleutheroside B purified in step S4 in Example 1;

[0029] Figure 7 This is the HPLC preparation diagram of eleutheroside B after salt conversion in step S5 of Example 1;

[0030] Figure 8 The HPLC test result of the eleutheroside B sample finally obtained in Example 1;

[0031] Fig. 9 The HPLC test result of the eleutheroside E sample obtained in step S2 of Example 2;

[0032] Fig.10 This is a HPLC preparation diagram of eleutheroside E obtained after separation and purification in step S3 of Example 2;

[0033] Fig.11 The HPLC test result of the eleutheroside E sample obtained in step S3 of Example 2;

[0034] Fig.12 This is the HPLC preparation diagram of eleutheroside E purified in step S4 of Example 2;

[0035] Fig.13 The HPLC test result of the eleutheroside E sample obtained in step S4 of Example 2;

[0036] Fig.14 This is the HPLC preparation diagram of eleutheroside E obtained by salt conversion in step S5 of Example 2;

[0037] Fig.15 The HPLC test result of the eleutheroside E sample finally obtained in Example 2;

[0038] Fig.16 This is a flow chart for the preparation of eleutheroside B and eleutheroside E extracts in the examples. DETAILED DESCRIPTION

[0039] Those skilled in the art can refer to the content of this article and appropriately improve the process parameters. It should be particularly noted that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method and application of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein without departing from the content and scope of the present invention to implement and apply the technology of the present invention.

[0040] In order to make the purpose, technical scheme and advantages of the present invention more clear, the present invention is further described in detail below in conjunction with specific implementation methods and the accompanying drawings of the specification. The experimental methods used in the following examples are conventional methods unless otherwise specified, and the materials, reagents, methods and instruments used are conventional materials, reagents, methods and instruments in the art unless otherwise specified, and can be obtained by those skilled in the art through commercial channels.

[0041] Example 1

[0042] S1: Take 3kg of Acanthopanax senticosus extract and add 13500ml of methanol, dissolve by ultrasonic for 30 minutes, soak for 1 hour, let stand until the sample precipitates, take the supernatant and filter, repeat 3 times to obtain Acanthopanax senticosus mixed solution, the quality inspection chart of Acanthopanax senticosus extract before preparation is as follows: Figure 1 As shown;

[0043] S2: The mixed solution of Acanthopanax senticosus obtained in S1 was diluted 6 times, and methanol was used as the organic phase and 0.1% trifluoroacetic acid aqueous solution was used as the inorganic phase. The proportion of the organic phase was increased from 20% to 47.5% in 55 min for elution (such as Figure 2 As shown), when the peaks are eluted, one peak is collected in one collection cup, and after the collection is completed, the sample of eleutheroside B with a purity greater than 80% is obtained (as shown in Figure 3 shown);

[0044] S3: Take the sample of Acanthopanax glycoside B with a purity greater than 80% obtained in S2, distill under reduced pressure in a water bath at 30°C for 30 minutes, use acetonitrile as the organic phase and 0.1% trifluoroacetic acid aqueous solution as the inorganic phase, and increase the organic phase ratio from 5% to 22% in 51 minutes for elution. Collect samples according to the peak shape and perform detection (such as Figure 4 As shown), a sample of eleutheroside B with a purity greater than 90% was obtained (as shown Figure 5 shown);

[0045] S4: Take the sample of Acanthopanax glycoside B with a purity greater than 90% obtained in S3, and distill it under reduced pressure in a water bath at 30°C for 30 minutes. After injection, rinse with 5% acetonitrile and 95% 50mmol ammonium acetate solution for 15 minutes, and then rinse with 5% acetonitrile and 95% 0.08% acetic acid aqueous solution for 15 minutes. During elution, acetonitrile and 0.08% acetic acid aqueous solution are used as organic phases, and the organic phase ratio is increased from 5% to 22% in 51 minutes for elution. Collect samples according to the peak shape and detect (such as Figure 6 As shown), a sample of eleutheroside B with a purity greater than 98% was obtained;

[0046] S5: Add one volume of water to the sample of eleutheroside B with a purity greater than 98% obtained in S4 for dilution, rinse with 5% acetonitrile and 95% 50mmol ammonium acetate solution for 15 minutes, and then rinse with 5% acetonitrile and 95% purified water for 15 minutes. When eluting, use acetonitrile and purified water as the organic phase, and rinse isocratically when the organic phase ratio is 30%. Collect all samples before the inflection point (such as Figure 7 As shown), to obtain the eleutheroside B sample after salt conversion;

[0047] S6: Take the sample of eleutheroside B obtained in S5 after salt conversion, water bath at 30°C, vacuum distill for 2h, raise the water bath temperature to 33°C, vacuum distill for 4h, freeze-dry after vacuum distillation, and obtain freeze-dried powder of eleutheroside B. The freeze-dried powder of eleutheroside B finally obtained in this example was tested, and the results were as follows: Figure 8 As shown, 12 g of freeze-dried powder of Acanthopanax senticosus glycoside B was obtained, with a purity of more than 95%.

[0048] Example 2

[0049] S1: Take 3kg of Acanthopanax senticosus extract and add 13500ml of methanol, dissolve by ultrasonic for 30 minutes, soak for 1 hour, let stand until the sample precipitates, take the supernatant and filter, repeat 3 times to obtain Acanthopanax senticosus mixed solution, the quality inspection chart of Acanthopanax senticosus extract before preparation is as follows: Figure 1 As shown;

[0050] S2: The mixed solution of Acanthopanax senticosus obtained in S1 was diluted 6 times, and methanol was used as the organic phase and 0.1% trifluoroacetic acid aqueous solution was used as the inorganic phase. The proportion of the organic phase was increased from 20% to 47.5% in 55 min for elution (such as Figure 2 As shown), when the peaks are eluted, one peak is collected in one collection cup, and after the collection is completed, the sample of eleutheroside E with a purity greater than 80% is obtained (as shown Fig. 9 shown);

[0051] S3: Take the sample of Acanthopanax glycoside E with a purity greater than 80% obtained in S2, distill under reduced pressure in a water bath at 30°C for 30 minutes, use acetonitrile as the organic phase and 0.1% trifluoroacetic acid aqueous solution as the inorganic phase, and increase the organic phase ratio from 25% to 35% in 50 minutes for elution. Collect samples according to the peak shape and perform detection (such as Fig.10 As shown), a sample of eleutheroside E with a purity greater than 90% was obtained (as shown Fig.11 shown);

[0052] S4: Take the sample of Acanthopanax glycoside E obtained in S3 with a purity greater than 90%, and distill under reduced pressure in a water bath at 30°C for 30 minutes. After injection, rinse with 5% acetonitrile and 95% 50mmol ammonium acetate solution for 15 minutes, and then rinse with 5% acetonitrile and 95% 0.08% acetic acid aqueous solution for 15 minutes. During elution, acetonitrile and 0.08% acetic acid aqueous solution are used as organic phases, and the proportion of organic phase is increased from 23% to 33% in 50 minutes for elution. Collect samples according to peak shape and detect (such as Fig.12 As shown), a sample of eleutheroside E with a purity greater than 98% was obtained (as shown Fig.13 shown);

[0053] S5: Add one volume of water to the sample of eleutheroside E with a purity greater than 98% obtained in S4 for dilution, rinse with 5% acetonitrile and 95% 50mmol ammonium acetate solution for 15 minutes, and then rinse with 5% acetonitrile and 95% purified water for 15 minutes. When eluting, use acetonitrile and purified water as the organic phase, and rinse isocratically when the organic phase ratio is 30%. Collect all samples before the inflection point (such as Fig.14 As shown), to obtain the eleutheroside E sample after salt conversion;

[0054] S6: Take the sample of the eleutheroside E obtained in S5 after salt conversion, place it in a water bath at 30°C, and perform vacuum distillation for 2 hours. Raise the water bath temperature to 33°C, and perform vacuum distillation for 4 hours. After the vacuum distillation is completed, freeze-dry to obtain freeze-dried powder of eleutheroside B.

[0055] In this example, the lyophilized powder of Acanthopanax senticosus glycoside E finally obtained was tested. The results are as follows: Fig.15 As shown, 4 g of lyophilized powder of Acanthopanax senticosus glycoside E was obtained, with a purity of more than 95%.

[0056] The preparation flow chart of eleutheroside B and eleutheroside E extracts in this embodiment is as follows: Fig.16 As shown, the present invention takes the extraction of Acanthopanax glycosides B and E as an example. If other components in Acanthopanax are to be extracted, please select them according to the corresponding extract peaks in the reverse phase chromatography separation and purification step.

[0057] The contents not described in detail in the specification of the present invention are well-known technologies for those skilled in the art. Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention should be based on the definition of the claims.

Claims

1. A method for preparing an extract of Acanthopanax senticosus extract, characterized in that: The preparation method comprises the following steps: S1: using methanol to dissolve the Acanthopanax senticosus extract, filtering and discarding the residue, repeating the above dissolving and filtering steps 3 times to obtain an Acanthopanax senticosus mixed solution; S2: using high performance liquid chromatography to separate and purify the Acanthopanax senticosus mixed solution obtained in S1 to obtain a crudely purified Acanthopanax senticosus mixed solution; S3: Select the crudely purified Acanthopanax senticosus single component solution obtained in S2, purify and convert the solution into salt by high performance liquid chromatography, perform vacuum distillation, and freeze-dry to obtain a purified single component Acanthopanax senticosus extract.

2. The method according to claim 1, characterized in that The dissolution treatment in S1 is to dissolve for 30 minutes under ultrasonic conditions.

3. The method according to claim 1, characterized in that The filtration described in S1 is performed using a filter membrane with a pore size of 0.45 um.

4. The method according to claim 1, characterized in that: The separation and purification step described in S2 is: using methanol as the organic phase, trifluoroacetic acid / water solution as the inorganic phase, and C18 silica gel column as the stationary phase, and using high performance liquid chromatography to separate and purify; the concentration of the trifluoroacetic acid solution is 0.1%.

5. The method according to claim 1, characterized in that The purification step described in S3 is: using acetonitrile solution as the organic phase, trifluoroacetic acid / water or acetic acid aqueous solution as the inorganic phase, and C18 silica gel column as the stationary phase, and purifying by high performance liquid chromatography; the concentration of the acetonitrile solution is 5%, and the concentration of the acetic acid aqueous solution is 0.08%.

6. The method according to claim 1, characterized in that The single-ingredient Acanthopanax senticosus extract described in S3 is any one of eleutheroside A, eleutheroside B, eleutheroside C, eleutheroside D, eleutheroside E, eleutheroside F or eleutheroside G extract.

7. The method according to claim 1, characterized in that The salt conversion step described in S3 is: first, the sample is rinsed with acetonitrile and ammonium acetate solution, then with acetonitrile and acetic acid aqueous solution, and finally, the sample is eluted with water and acetonitrile as mobile phases; the concentration of the ammonium acetate solution is 50 mmol.

8. The method according to claim 1, characterized in that The vacuum distillation step described in S3 is: first, vacuum distillation for 2 h in a water bath at 30° C., and then, vacuum distillation for 4 h in a water bath at 33° C.

9. An extract of Acanthopanax senticosus extract, characterized in that: The Acanthopanax senticosus extract is obtained by the preparation method described in any one of claims 1 to 8.

10. Use of the Acanthopanax senticosus extract according to claim 9 in the preparation of Acanthopanax senticosus medicine.